Skip to content

Change in AP at other companies

Rogers Corporation logo
Rogers CorporationROG
$8.1M+92.9%
Vera Therapeutics logo
Vera TherapeuticsVERA
-$7.97M-599%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-$4.99M-77.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$7.17M-141%
Kiniksa Pharmaceuticals International, plc logo
Kiniksa Pharmaceuticals International, plcKNSA
$22.27M+35,813%
Alumis Inc. logo
Alumis Inc.ALMS
$1.43M+167%

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.3B+78.5%
Enterprise value$2.34B+78.3%
P/E7.7×-24.6×
P/S7.7×+2.5×

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's change in AP?
Aurinia Pharmaceuticals (AUPH) reported change in AP of -$652K in Q1 2026.
How has Aurinia Pharmaceuticals's change in AP changed year-over-year?
Aurinia Pharmaceuticals's change in AP increased by 33.1% year-over-year, from -$974K to -$652K.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.